[The treatment of deep venous thrombosis with low-molecular-weight heparin].
The authors, via a long review of published studies, show that low-molecular weight heparin, with early start of antivitamin K, is actually the treatment of choice in thromboembolic disease.
D000925:Anticoagulants / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic; D013923:Thromboembolism / Q000188:drug therapy*; D014812:Vitamin K / Q000037:antagonists & inhibitors
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D014812:Vitamin K
Le traitement des thromboses veineuses profondes par les héparines de bas poids moléculaire.